To investigate this unexpectedly high incidence in more detail, we analyzed normal breast tissues of ten women without diagnosed breast cancer, 16 benign fibroadenomas and 13 ductal carcinomas in situ (DCIS) tissues, all of them ESR1-positive. This evidence concerns the gene ESR1 and ductal breast carcinoma in situ.